Challenges in the Manufacture of Antibody Drug Conjugates

Antibody drug conjugates (ADCs) represent potent new weapons in the anticancer drug arsenal – but their manufacture presents a series of engineering and chemistry challenges.

By Thomas Roher at Lonza Custom Manufacturing, Chemical Manufacturing (March 2010)

Keywords: manufacture, Lonza, ADC, Antibody, weapon, drug, cancer, molecule, chemotherapeutic, silver bullet, challenge, Rohrer

View full article    |    Back to Manufacturing section